Your browser doesn't support javascript.
loading
EXPAND, a dose-finding study of ruxolitinib in patients with myelofibrosis and low platelet counts: 48-week follow-up analysis.
Vannucchi, Alessandro M; Te Boekhorst, Peter A W; Harrison, Claire N; He, Guangsheng; Caramella, Marianna; Niederwieser, Dietger; Boyer-Perrard, Françoise; Duan, Minghui; Francillard, Nathalie; Molloy, Betty; Wroclawska, Monika; Gisslinger, Heinz.
Afiliação
  • Vannucchi AM; Center for Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliero Universitaria Careggi, University of Florence, Italy amvannucchi@unifi.it.
  • Te Boekhorst PAW; Erasmus Medical Center, Rotterdam, the Netherlands.
  • Harrison CN; Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK.
  • He G; No. 1 Hospital of Nanjing Medical University, China.
  • Caramella M; ASST Grande Ospedale Metropolitano, Milano, Italy.
  • Niederwieser D; Department of Hematology and Medical Oncology, University of Leipzig, Germany.
  • Boyer-Perrard F; Centre Hospitalier Universitaire d'Angers, France.
  • Duan M; Peking Union Medical College Hospital, Beijing, China.
  • Francillard N; Novartis Pharma S.A.S, Rueil Malmaison, France.
  • Molloy B; Novartis AG, Basel, Switzerland.
  • Wroclawska M; Novartis AG, Basel, Switzerland.
  • Gisslinger H; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Austria.
Haematologica ; 104(5): 947-954, 2019 05.
Article em En | MEDLINE | ID: mdl-30442723
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Inibidores de Proteínas Quinases / Mielofibrose Primária Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Inibidores de Proteínas Quinases / Mielofibrose Primária Idioma: En Ano de publicação: 2019 Tipo de documento: Article